PURE Bioscience, Inc.

PURE · OTC
Analyze with AI
7/31/2025
7/31/2024
7/31/2023
7/31/2022
Operating Activities
Net Income-$2,399-$3-$4-$3
Dep. & Amort.$2$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$147$0$0$1
Change in WC$0$0-$0$0
Other Non-Cash$235$0$0$0
Operating Cash Flow-$2,015-$3-$3-$2
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0-$0
Financing Activities
Debt Repay.$2$2$1$0
Stock Issued$0$0$0$4
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1,998$0$0$0
Financing Cash Flow$2,000$2$1$4
Forex Effect$0$0$0$0
Net Chg. in Cash-$15-$1-$2$1
Supplemental Information
Beg. Cash$424$1$3$2
End Cash$409$0$1$3
Free Cash Flow-$2,015-$3-$3-$2
PURE Bioscience, Inc. (PURE) Financial Statements & Key Stats | AlphaPilot